X0303 4/A 2007-10-11 2007-10-11 0 0001401923 MAP Pharmaceuticals, Inc. MAPP 0001296771 Freund John Gordon C/O SKYLINE VENTURES 525 UNIVERSITY AVENUE, SUITE 520 PALO ALTO CA 94301 1 0 0 0 Common Stock 2007-10-11 4 J 0 128862 14.502 A 212195 I See Footnote Common Stock 2007-10-11 4 C 0 1638798 14.502 A 1850993 I See Footnote Series B Preferred Stock 2007-10-11 2007-10-11 4 C 0 779872 14.502 D Common Stock 779872 0 D Represents 123,306 shares held by Skyline Venture Partners Qualified Purchaser Fund III, L.P. ("SVPQFIII"), 3,068 shares held by Skyline Venture Partners III, L.P. ("SVPIII") and 2,488 shares held by Skyline Expansion Fund, L.P. ("SEF") received pursuant to the cumulative stock dividend. This also represents 83,333 shares held by SEF previously reported by the Reporting Person on a Form 4 filing. This amendment corrects the number of shares held by each of SVPQFIII, SVPIII and SEF. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Represents the aggregate cumulative holdings, including the shares represented in footnote 1 above, of SVPQFIII of 1,645,733 shares, SVPQFIII of 40,971 shares and SEF of 164,289 shares. This amendment corrects the number of shares held by each of SVPQFIII, SVPIII and SEF and also represents an increase of one share beneficially owned by the Reporting Person. Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. This amendment corrects the number of shares of common stock issued upon conversion of the issuer's Series B Preferred Stock by one additional share. All outstanding shares of the issuer's preferred stock were automatically converted into common stock on a 1-for-1 basis upon the closing of the issuer's initial public offering, for no additional consideration. Not applicable, see Note 4. /s/ John G. Freund, M.D. 2010-03-16